Marine microalgae and their industrial biotechnological applications: A review.

Background: For use in specialized programs in the food, pharmaceutical, nutraceutical, cosmetic, and animal feed sectors, micro-algal biomass has been generated industrially. They can be grown in closed buildings, such as photobioreactors, or open structures. The utilization of biomass from microalgae for energy production is another crucial topic.

Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.

Backgrounds: A worldwide coronavirus pandemic has affected many healthcare systems in 2019 (COVID-19). Following viral activation, cytokines and chemokines are released, causing inflammation and tissue death, particularly in the lungs, resulting in severe COVID-19 symptoms such as pneumonia and ARDS. COVID-19 induces the release of several chemokines and cytokines in different organs, such as the cardiovascular system and lungs.

Modulation of MAPK/NF-κB Pathway and NLRP3 Inflammasome by Secondary Metabolites from Red Algae: A Mechanistic Study.

The pharmacological properties of seaweeds are diverse. No studies have been conducted on the protective effect of (GOE) against lippopolysaccharide (LPS)-induced inflammation in the brain. This study is divided into three phases, the first of which is the initial phase.

Quantifying microplastics pollution in the Red Sea and Gulfs of Suez and Aqaba: Insights from chemical analysis and pollution load assessment.

Microplastics (MPs) constitute the majority of marine plastic litter. The pollution caused by MPs has been categorized as a gradual and persistent crisis, but little is known about its extent along the shores of the Red Sea, particularly on the Egyptian side. The Red Sea is a rapidly developing region and home to critical ecosystems with high levels of endemism.